|
Status |
Public on Jun 15, 2016 |
Title |
Gene expression of Lymphoblastoid Cell Lines (LCLs) from Depressed Patients after in-vitro treatment with fluoxetine |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
We used whole gene gene expression profiling to identify potential gene expression biomarkers associated for the treatment individualization of depressive disorders.
|
|
|
Overall design |
Gene expression was measured after 21 days of in-vitro treatment with therapeutical concentrations of fluoxetine in n=10 LCLs derived from depressed patients with documented clinical treatment outcome.
|
|
|
Contributor(s) |
Breitfeld J, Scholl C, Steffens M, Stingl J |
Citation(s) |
27845776 |
Submission date |
Jun 15, 2016 |
Last update date |
Sep 27, 2019 |
Contact name |
Julia Carolin Stingl |
Organization name |
Federal Institute for Drugs and Medical Devices
|
Department |
Research
|
Street address |
Kurt-Georg-Kiesinger Allee 3
|
City |
Bonn |
ZIP/Postal code |
53175 |
Country |
Germany |
|
|
Platforms (1) |
GPL17077 |
Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version) |
|
Samples (20)
|
|
Relations |
BioProject |
PRJNA325746 |